Navigation Links
Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find
Date:8/18/2008

In up to 20 percent of people infected with HIV, the virus manages to escape from the bloodstream and cross into the brain, resulting in HIV-associated dementia and other cognitive disorders. Now, scientists at the Albert Einstein College of Medicine of Yeshiva University have found strong evidence that a component of the cell walls of intestinal bacteriaa chemical present in high levels in the blood of HIV-infected peoplehelps HIV to penetrate the usually-impregnable blood brain barrier (BBB). The findings, published in the August issue of the Journal of Virology, could lead to strategies for preventing HIV from entering the brain and causing serious complications.

"Previous research has suggested that it's not individual HIV viruses that get into the brain but rather HIV-infected immune cells known as monocytes," says Dr. Harris Goldstein, director of the Einstein-Montefiore Medical Center for AIDS Research and senior author of the study. "Using an animal model, we wanted to find out first of all whether being infected with HIV enables monocytes to do what they don't usually doescape from blood vessels and enter brain tissue."

Overcoming HIV's inability to infect mice, Dr. Goldstein and his colleagues had previously created a transgenic mouse line, HIV-TG mice, equipped with all the genes needed to make HIVand that produces HIV in those cells, including monocytes and T cells, in which the virus multiplies in people. The HIV-TG mice were then bred with another transgenic mouse line, GFP-TG mice, containing the gene that codes for green fluorescent protein (GFP). The result: a double transgenic mouse line, HIV/GFP-TG mice, whose HIV-infected monocytes carried the GFP gene. This meant that the monocytes could be detectedeither by looking for glowing green cells under the microscope or by using polymerase chain reaction, a sensitive genetic assay capable of detecting the DNA of the GFP gene.

Next, the researchers isolated m
'/>"/>

Contact: Michael Heller
mheller@aecom.yu.edu
718-430-4186
Albert Einstein College of Medicine
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Black Henna Tattoo Chemical Can Cause Skin Reaction
2. Lawmakers Agree to Ban Dangerous Chemicals in Toys
3. Most Influential Events for Koreas Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November
4. Stay Safe This Summer With Chemical-Free Sunscreen and DEET-Free Bug Repellent, Says Natural Solutions Magazine
5. Clean, Chemical-Free Eye Cream Evening Primrose Oil: The Puffy-Eye Cure
6. SIDS Linked to Brain Chemical Dysfunction
7. CEVA Logistics Awarded Best 3PL Provider for Pharmaceutical, Chemical, HazMat and Fresh Food Supply Chains
8. American Chemical Societys Weekly PressPac -- June 18, 2008
9. American Chemical Societys Weekly PressPac: June 11, 2008
10. UCR chemists use green chemistry to produce amines, chemical compounds used widely in industry
11. Pfizers work on penicillin for World War II becomes a National Historic Chemical Landmark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find
Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find
Other Medicine News:Health News:XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress 2Health News:XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress 3Health News:XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress 4Health News:Veterans Organizations Call For Early Lung Cancer Detection Research 2Health News:HLTH Corporation Announces Fourth Quarter Financial Results 2Health News:HLTH Corporation Announces Fourth Quarter Financial Results 3Health News:HLTH Corporation Announces Fourth Quarter Financial Results 4Health News:HLTH Corporation Announces Fourth Quarter Financial Results 5Health News:HLTH Corporation Announces Fourth Quarter Financial Results 6Health News:HLTH Corporation Announces Fourth Quarter Financial Results 7Health News:HLTH Corporation Announces Fourth Quarter Financial Results 8Health News:HLTH Corporation Announces Fourth Quarter Financial Results 9Health News:HLTH Corporation Announces Fourth Quarter Financial Results 10Health News:HLTH Corporation Announces Fourth Quarter Financial Results 11Health News:HLTH Corporation Announces Fourth Quarter Financial Results 12Health News:HLTH Corporation Announces Fourth Quarter Financial Results 13Health News:HLTH Corporation Announces Fourth Quarter Financial Results 14Health News:HLTH Corporation Announces Fourth Quarter Financial Results 15Health News:HLTH Corporation Announces Fourth Quarter Financial Results 16Health News:HLTH Corporation Announces Fourth Quarter Financial Results 17Health News:HLTH Corporation Announces Fourth Quarter Financial Results 18Health News:HLTH Corporation Announces Fourth Quarter Financial Results 19Health News:HLTH Corporation Announces Fourth Quarter Financial Results 20Health News:HLTH Corporation Announces Fourth Quarter Financial Results 21Health News:CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture 2Health News:CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture 3Health News:CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture 4
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 618th Annual Texas Autism Conference Returns To Corpus Christi Makes Nearly 24300 000 Economic Impact 62267 118th Annual Texas Autism Conference Returns To Corpus Christi Makes Nearly 24300 000 Economic Impact 62267 2OmniActive and Kemin Reach Amicable Settlement in Patent Dispute 62262 1Advanced Health Media Honored at NJ Finest Award Ceremony 62257 1Advanced Health Media Honored at NJ Finest Award Ceremony 62257 2